API exports in 2025 are no longer just a supply chain metric, they have become an important essence of the global pharmaceutical industry.Read More
The pharmaceutical industry's conference landscape is rapidly changing. AI-powered drug discovery dominating biotech events.Read More
Explore 2025 biosimilar approval trends, regional bottlenecks, and why most applications fail despite rising global market demand.Read More
The U.S. Food and Drug Administration (FDA) sets the global gold standard for drug regulation.Read More
India isn’t just a pharma market. It’s the engine that powers global access to affordable medicine.Read More
AI is transforming the pharmaceutical industry in 2025—driving breakthroughs in drug discovery, optimizing manufacturing, and fixing broken supply chains.Read More
2025 is turning out to be one of the most pivotal years for pharmaceutical M&A activity in recent history.Read More
In June 2025, the government imposed anti-dumping duties on four chemicals—most of them sourced from China.Read More
As we move deeper into 2025, biosimilars are gaining unprecedented traction.Read More
When it comes to global demand, few active pharmaceutical ingredients rival Ibuprofen, a widely trusted, fast-acting NSAID used across hospitals, retail shelves, and emergency protocols.Read More